These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32059750)

  • 21. Comparison between α-synuclein wild-type and A53T mutation in a progressive Parkinson's disease model.
    Lu J; Sun F; Ma H; Qing H; Deng Y
    Biochem Biophys Res Commun; 2015 Sep; 464(4):988-993. PubMed ID: 26192120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.
    Betarbet R; Canet-Aviles RM; Sherer TB; Mastroberardino PG; McLendon C; Kim JH; Lund S; Na HM; Taylor G; Bence NF; Kopito R; Seo BB; Yagi T; Yagi A; Klinefelter G; Cookson MR; Greenamyre JT
    Neurobiol Dis; 2006 May; 22(2):404-20. PubMed ID: 16439141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetramethylpyrazine Analogue T-006 Promotes the Clearance of Alpha-synuclein by Enhancing Proteasome Activity in Parkinson's Disease Models.
    Zhou H; Shao M; Guo B; Li C; Lu Y; Yang X; ShengnanLi ; Li H; Zhu Q; Zhong H; Wang Y; Zhang Z; Lu J; Lee SM
    Neurotherapeutics; 2019 Oct; 16(4):1225-1236. PubMed ID: 31313223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silica nanoparticles induce alpha-synuclein induction and aggregation in PC12-cells.
    Xie H; Wu J
    Chem Biol Interact; 2016 Oct; 258():197-204. PubMed ID: 27613482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel 1-hydroxypyridin-2-one metal chelators prevent and rescue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson's disease.
    Lewis FW; Fairooz S; Elson JL; Hubscher-Bruder V; Brandel J; Soundararajan M; Smith D; Dexter DT; Tétard D; Pienaar IS
    Arch Toxicol; 2020 Mar; 94(3):813-831. PubMed ID: 32078022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein.
    Ebrahimi-Fakhari D; Cantuti-Castelvetri I; Fan Z; Rockenstein E; Masliah E; Hyman BT; McLean PJ; Unni VK
    J Neurosci; 2011 Oct; 31(41):14508-20. PubMed ID: 21994367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UBA52 Is Crucial in HSP90 Ubiquitylation and Neurodegenerative Signaling during Early Phase of Parkinson's Disease.
    Tiwari S; Singh A; Gupta P; Singh S
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagy and UPS pathway contribute to nicotine-induced protection effect in Parkinson's disease.
    Ullah I; Uddin S; Zhao L; Wang X; Li H
    Exp Brain Res; 2024 Apr; 242(4):971-986. PubMed ID: 38430248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptor 4 deficiency facilitates α-synuclein propagation and neurodegeneration in a mouse model of prodromal Parkinson's disease.
    Venezia S; Kaufmann WA; Wenning GK; Stefanova N
    Parkinsonism Relat Disord; 2021 Oct; 91():59-65. PubMed ID: 34530328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration.
    Van Rompuy AS; Oliveras-Salvá M; Van der Perren A; Corti O; Van den Haute C; Baekelandt V
    Mol Neurodegener; 2015 Jun; 10():23. PubMed ID: 26099628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson's disease.
    von Hövel FF; Rumpel R; Ratzka A; Schreiner D; Grothe C
    Cell Tissue Res; 2019 Oct; 378(1):1-14. PubMed ID: 30989398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
    Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
    Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deubiquitinase Usp8 regulates α-synuclein clearance and modifies its toxicity in Lewy body disease.
    Alexopoulou Z; Lang J; Perrett RM; Elschami M; Hurry ME; Kim HT; Mazaraki D; Szabo A; Kessler BM; Goldberg AL; Ansorge O; Fulga TA; Tofaris GK
    Proc Natl Acad Sci U S A; 2016 Aug; 113(32):E4688-97. PubMed ID: 27444016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emotional memory impairments induced by AAV-mediated overexpression of human α-synuclein in dopaminergic neurons of the ventral tegmental area.
    Alvarsson A; Caudal D; Björklund A; Svenningsson P
    Behav Brain Res; 2016 Jan; 296():129-133. PubMed ID: 26341317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's Disease: Exploring Different Animal Model Systems.
    Khan E; Hasan I; Haque ME
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of SUMO-1 on mitochondria subcellular localization of alpha-synuclein and its degradation via ubiquitin-proteasome system].
    Chen T; Liao XP; Wen GQ; Nong ZG; Ouyang F; Deng YD; Guo M; Wu HL; Zhou P
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):267-71. PubMed ID: 20533263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitophagy Upregulation Occurs Early in the Neurodegenerative Process Mediated by α-Synuclein.
    Hui S; George J; Kapadia M; Chau H; Bariring Z; Earnshaw R; Shafiq K; Kalia LV; Kalia SK
    Mol Neurobiol; 2024 Nov; 61(11):9032-9042. PubMed ID: 38581539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
    Coune PG; Bensadoun JC; Aebischer P; Schneider BL
    J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
    Wu F; Xu HD; Guan JJ; Hou YS; Gu JH; Zhen XC; Qin ZH
    Neuroscience; 2015 Jan; 284():900-911. PubMed ID: 25446361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.